Advertisement

CD40-Expression in Thymoma

  • A. Schultz
  • A. Greiner
  • R. Nenninger
  • D. Schömig
  • A. Wilisch
  • E. Oswald
  • R. A. Kroczek
  • B. Schalke
  • H. K. Müller-Hermelink
  • A. Marx

Abstract

Overexpression of CD40 on neoplastic epithelium has been found in most Myasthenia gravis (MG) associated thymoma. Whether CD40 is functionally expressed in thymoma and is involved in the generation of autoimmunity, has not been elucidated. To check the function of CD40, the proliferation of thymic epithelial cells (TEC) was induced by triggering the cells with soluble CD40 ligand. No difference between normal and neoplastic TEC was detected. IFN-γ could not modulate the CD40-dependent proliferation. In contrast IL-4 blocked the proliferative response of epithelial cells from normal thymus and cortical thymoma, but not from medullary thymoma. Since CD40/CD40 ligand interaction has been implicated in negative selection of immature T-cells, we compared the number of positively selected (immature) double positive CD69+ thymocytes with the number of (mature) single positive CD69+ cells, which are thought to have escaped negative selection. The ratio of mature to immature thymocytes was markedly reduced in thymoma. One explanation might be an enhanced deletion of positively selected thymocytes. Our results demonstrated, that CD40 is functionally expressed on normal and neoplastic epithelial cells in vitro. The data suggest, that maturation of autoaggressive T-cells in paraneoplastic MG is probably not caused by an unspecific inefficiency of negative selection.

Keywords

Negative Selection CD40 Ligand Thymic Carcinoma Thymic Epithelial Cell Normal Thymus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Armitage R. J.; Tough T.W.; Macduff B. M. (1993, I) CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23: 2326.PubMedCrossRefGoogle Scholar
  2. Armitage R.J.; Macduff B.M.; Spriggs M.K.; Fanslow W. C. (1993, II) Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150(9): 3671.PubMedGoogle Scholar
  3. Carlow D. A.; van Oers N. S. C; Teh S.-J.; The H.-S. (1992) Deletion of antigen-specific immature thymocytes by dendritic cells requires LFA-1/ICAM interations. J. Immunol. 148: 1595.PubMedGoogle Scholar
  4. Cayabyab M.; Phillips J. H. Lanier L. L. (1994) CD40 preferentially costimulates activation of CD4+ T Lymphocytes. J. Immunol. 152: 1523PubMedGoogle Scholar
  5. Clark E.A.; Ledbetter J. A. (1986) Activation of human B cells mediated through two distinc cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83: 4494.PubMedCrossRefGoogle Scholar
  6. Foy T.M.; Page D.M.; Waldschmidt T.J.; Schoneveld A.; Laman J.D.; Masters S.R.; Tygrett L.; Ledbetter J.A.; Aruffo A.; Claassen E.; Xu J. C; Flavell R. A.; Oehen S.; Hedrichk S. M.; Noelle R. J. (1995) An essential role for gp 39, the ligand for CD40, in thymic selection. J. Exp. Med. 182: 1377.PubMedCrossRefGoogle Scholar
  7. Galy A. H. M.; Spits H. (1992) CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149: 775.PubMedGoogle Scholar
  8. Huettner C; Paulus W.; Roggendorf W. (1995) Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am. J. Pathol. 146: 317.PubMedGoogle Scholar
  9. Marx A.; Kirchner T.; Hoppe F.; O’Connor R.; Schalke B.; Tzartos S.; Müller-Hermelink H. K. (1989) Protein with epitopes of the acetylcholine receptor in epithelial cell cultur of thymomas in myastenia gravis. Am. J. Pathol. 134:865.PubMedGoogle Scholar
  10. Marx A.; Wilisch A.; Schultz A.; Greiner A.; Magi B.; Pallini V.; Schalke B.; Toyka K.; Nix W.; Kirchner T.; Müller-Hermelink H.K. (1996) Expression of neurofilaments and of titin-epitope in thymic epithelial tumors: implications for the pathogenesis of Myasthenia gravis. Am. J. Pathol. 148: 1839–1850.PubMedGoogle Scholar
  11. Mat I.; Melcher D.; Ritter M.A. (1991) Epithelial cell expression of InterIeukin-4 receptor complex. Lymphatic tissues and in vivo immune responses. Edited by Imhof B. A.; Berrih-Aknin S.; Ezine S. Marcel Dekker, Inc. 27Google Scholar
  12. Müller-Hermelink H.K.; Marx A.; Geuder K.I.; Kirchner T. (1993) The pathological basis of thymoma-associated Myasthenia gravis. Ann N. Y. Acad. Sci: 681: 56.PubMedCrossRefGoogle Scholar
  13. Müller-Hermelink H.K.; Marx A.; Kirchner T. (1994) Advances in the diagnosis and classification of thymic epithelial tumors. Rec Adv Histopathol 1994, 16: 49.Google Scholar
  14. Pircher H.; Ohashi P.S.; Boyd R.L.; Hengartner H.; Brduscha K. (1994) Evidence for a selective and multi-step model of T-cell differentiation: CD4+CD8low thymocytes selected by a transgenic T-cell receptor on major histocompatibility complex class I molecules. Eur. J. Immunol. 24: 1982PubMedCrossRefGoogle Scholar
  15. Punt J.A.; Osborne B.A.; Takahama Y.; Sharrow S.; Singer A. (1994) Negative Selection of CD4+ and CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J. Exp. Med. 179: 709.PubMedCrossRefGoogle Scholar
  16. Renshaw B.R.; Fanslow III; Armitage R.J.; Campbell K.A.; Liggitt D.; Wright B.; Davison B.L.; Maliszewski C. R. (1994) Humoral immune response in CD40 ligand-deficient mice. J. Exp. Med. 180: 1889.PubMedCrossRefGoogle Scholar
  17. Ritter M.A.; Boyd R.L; (1993): Development in the thymus: it takes two to tango. Immmunol. today 51: 462.CrossRefGoogle Scholar
  18. Swat W.; Dessing M.; Boehmer H.; Kisielow P. (1992) CD69 expression during selection and maturation of CD4+ CD8+ thymocytes. Eur. J. Immunol. 23: 739.CrossRefGoogle Scholar
  19. Takahama Y; Suzuki H.; Katz K.S.; Grusby M.J.; Singer A. (1994) Positive selection of CD4+ T cells by TCR ligation without aggregation even in the absence of MHC. Nature 371: 67.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • A. Schultz
    • 1
  • A. Greiner
    • 1
  • R. Nenninger
    • 1
  • D. Schömig
    • 1
  • A. Wilisch
    • 1
  • E. Oswald
    • 1
  • R. A. Kroczek
    • 2
  • B. Schalke
    • 3
  • H. K. Müller-Hermelink
    • 1
  • A. Marx
    • 1
  1. 1.Institute of PathologyUniversity of WürzburgGermany
  2. 2.Robert-Koch-InstituteBerlinGermany
  3. 3.Department of NeurologyUniversity of WürzburgGermany

Personalised recommendations